Cervical cancer screening

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There is abundant evidence that cervical cancer screening with conventional cytology (CC) has reduced mortality from cervical cancer. Based on the evidence, CC has been implemented as a modality of the population-based screening for the last several decades in Japan. Several issues are currently faced during screening. For instance, very low coverage is one of the greatest unsolved problems. At the same time, a reliable system is required to monitor specimen adequacy and to calculate detection rates of not only invasive cancer, but also cervical intraepithelial neoplasia (CIN), for the quality control and evaluation of screening efficacy. Recently, two new modalities may be applicable for cervical cancer screening. One is liquid-based cytology (LBC) and the other is the HPV test. LBC and CC did not differ significantly in terms of sensitivity and specificity for detection of CIN2+or CIN3+. HPV tests are superior to CC in sensitivity but are inferior in specificity for detection of CIN2+or CIN3+. Because there is a possibility reducing mortality from and incidence of invasive cervical cancer, implementation of these modalities to Japan should be taken into consideration. Prior to this, however, it is necessary to organize a system to compare performance indicators reflecting the effectiveness of the new modalities to those of CC in a population-based screening. Also, these results must be disclosed for a steady perspective on the cervical cancer screening in Japan.

Original languageEnglish
Pages (from-to)23-26
Number of pages4
JournalJapanese Journal of Cancer and Chemotherapy
Volume39
Issue number1
Publication statusPublished - 2012 Jan 15

Fingerprint

Early Detection of Cancer
Uterine Cervical Neoplasms
Cell Biology
Japan
Cervical Intraepithelial Neoplasia
Mortality
Quality Control
Population
Sensitivity and Specificity
Incidence
Neoplasms

Keywords

  • Cervical cancer screening
  • Conventional cytology
  • HPV tests
  • Implementation
  • Liquid-based cytology

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cervical cancer screening. / Aoki, Daisuke; Saito, Eiko; Tominaga, Eiichirou.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 39, No. 1, 15.01.2012, p. 23-26.

Research output: Contribution to journalArticle

@article{fd36ce143d854ed5b85800328ae16ed9,
title = "Cervical cancer screening",
abstract = "There is abundant evidence that cervical cancer screening with conventional cytology (CC) has reduced mortality from cervical cancer. Based on the evidence, CC has been implemented as a modality of the population-based screening for the last several decades in Japan. Several issues are currently faced during screening. For instance, very low coverage is one of the greatest unsolved problems. At the same time, a reliable system is required to monitor specimen adequacy and to calculate detection rates of not only invasive cancer, but also cervical intraepithelial neoplasia (CIN), for the quality control and evaluation of screening efficacy. Recently, two new modalities may be applicable for cervical cancer screening. One is liquid-based cytology (LBC) and the other is the HPV test. LBC and CC did not differ significantly in terms of sensitivity and specificity for detection of CIN2+or CIN3+. HPV tests are superior to CC in sensitivity but are inferior in specificity for detection of CIN2+or CIN3+. Because there is a possibility reducing mortality from and incidence of invasive cervical cancer, implementation of these modalities to Japan should be taken into consideration. Prior to this, however, it is necessary to organize a system to compare performance indicators reflecting the effectiveness of the new modalities to those of CC in a population-based screening. Also, these results must be disclosed for a steady perspective on the cervical cancer screening in Japan.",
keywords = "Cervical cancer screening, Conventional cytology, HPV tests, Implementation, Liquid-based cytology",
author = "Daisuke Aoki and Eiko Saito and Eiichirou Tominaga",
year = "2012",
month = "1",
day = "15",
language = "English",
volume = "39",
pages = "23--26",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "1",

}

TY - JOUR

T1 - Cervical cancer screening

AU - Aoki, Daisuke

AU - Saito, Eiko

AU - Tominaga, Eiichirou

PY - 2012/1/15

Y1 - 2012/1/15

N2 - There is abundant evidence that cervical cancer screening with conventional cytology (CC) has reduced mortality from cervical cancer. Based on the evidence, CC has been implemented as a modality of the population-based screening for the last several decades in Japan. Several issues are currently faced during screening. For instance, very low coverage is one of the greatest unsolved problems. At the same time, a reliable system is required to monitor specimen adequacy and to calculate detection rates of not only invasive cancer, but also cervical intraepithelial neoplasia (CIN), for the quality control and evaluation of screening efficacy. Recently, two new modalities may be applicable for cervical cancer screening. One is liquid-based cytology (LBC) and the other is the HPV test. LBC and CC did not differ significantly in terms of sensitivity and specificity for detection of CIN2+or CIN3+. HPV tests are superior to CC in sensitivity but are inferior in specificity for detection of CIN2+or CIN3+. Because there is a possibility reducing mortality from and incidence of invasive cervical cancer, implementation of these modalities to Japan should be taken into consideration. Prior to this, however, it is necessary to organize a system to compare performance indicators reflecting the effectiveness of the new modalities to those of CC in a population-based screening. Also, these results must be disclosed for a steady perspective on the cervical cancer screening in Japan.

AB - There is abundant evidence that cervical cancer screening with conventional cytology (CC) has reduced mortality from cervical cancer. Based on the evidence, CC has been implemented as a modality of the population-based screening for the last several decades in Japan. Several issues are currently faced during screening. For instance, very low coverage is one of the greatest unsolved problems. At the same time, a reliable system is required to monitor specimen adequacy and to calculate detection rates of not only invasive cancer, but also cervical intraepithelial neoplasia (CIN), for the quality control and evaluation of screening efficacy. Recently, two new modalities may be applicable for cervical cancer screening. One is liquid-based cytology (LBC) and the other is the HPV test. LBC and CC did not differ significantly in terms of sensitivity and specificity for detection of CIN2+or CIN3+. HPV tests are superior to CC in sensitivity but are inferior in specificity for detection of CIN2+or CIN3+. Because there is a possibility reducing mortality from and incidence of invasive cervical cancer, implementation of these modalities to Japan should be taken into consideration. Prior to this, however, it is necessary to organize a system to compare performance indicators reflecting the effectiveness of the new modalities to those of CC in a population-based screening. Also, these results must be disclosed for a steady perspective on the cervical cancer screening in Japan.

KW - Cervical cancer screening

KW - Conventional cytology

KW - HPV tests

KW - Implementation

KW - Liquid-based cytology

UR - http://www.scopus.com/inward/record.url?scp=84859012783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859012783&partnerID=8YFLogxK

M3 - Article

C2 - 22241349

AN - SCOPUS:84859012783

VL - 39

SP - 23

EP - 26

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 1

ER -